Subsequent KEGG pathway analysis demonstrated widespread participation of DE‐miRNAs in metabolic and oncogenic pathways (e.g., Ras/PI3K‐Akt [39]), directly linking WD‐associated metabolic abnormalities to hepatocellular carcinoma risk. This evidence concerns the gene AKT1 and Wilson disease.